Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Medical and Regulatory Affairs The Guardrails of GMOs: Regulatory Considerations for Gene Therapy Trials By Premier Research May 25, 2018 Clinical ResearchPhase 1 - Phase 4 Gene Therapy 101: From the 1960s to Today By Premier Research May 18, 2018 Consulting Nostalgia or Shell Shock? Assessing PTSD Is a Challenge by Any Name By Krista Armstrong May 11, 2018 Medical and Regulatory Affairs Are You Ready for the FDA’s eCTD Filing Deadline? That’s May 5, 2018. Yes. Tomorrow. By Premier Research May 4, 2018 Clinical ResearchPhase 1 - Phase 4 Six Ways to Help Manage Staff Trauma Exposure in PTSD Trials By Denise Bedoya April 23, 2018 Clinical ResearchPhase 1 - Phase 4 Boosting Immuno-Oncology’s Effectiveness Against Cancer By Premier Research April 19, 2018 Previous 1 …31 32 33 34 35 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today